Neurostimulation systems

Intellis™ Pro spinal cord stimulation system

Neurostimulation systems

Intellis™ Pro spinal cord stimulation system

The Intellis™ Pro spinal cord stimulation system aids in the management of certain types of chronic, intractable pain.

Ordering information
Contact a representative
Indications, Safety, and Warnings

Description

Built on the latest Medtronic SCS platform, Intellis™ Pro offers greater MRI access† and introduces new programming features allowing flexible patient programming in the smallest and thinnest SCS device.

Features

Best full-body 1.5T and 3T MRI access† with impedance independence


Intellis™ Pro patients can now access
95%
of MRI scanners vs. 68% with 1.5T only.1

   

Multiple waveform options allowing flexible patient programming

Patients now have a wider range of treatment options at their fingertips, enabling them to easily switch based on their changing preferences.

A man sitting in a chair checks his cell phone.

   

 

Smallest and thinnest designed for patient comfort

 

The Inceptiv™ spinal cord stimulator is designed to manage pain.

6 mm

DTM™ SCS has
been demonstrated to provide over
84%
responder rate in multiple studies including two RCTs.


Superior pain relief proven across multiple RCTs2,3

Decades of basic science research led up to the creation of Differential Target Multiplexed™ (DTM) spinal cord stimulation (SCS). DTM™ SCS was inspired by preclinical research demonstrating that DTM™ waveform can differentially modulate neurons and glial cells to balance interactions perturbed by neuropathic pain.3-5

Ordering information

Item number Description
977118 Intellis™ Pro rechargeable neurostimulator

Resources

Related links

Similar products

 † Under specific conditions. Refer to product labeling for full list of conditions. 

  1. Diagnostic Imaging Equipment Servicing. Market Insights. United States: Clarivate; 2022. Report No. 47031054.

  1. White T, Justiz R, Almonte W, et al. Twelve-month results from a randomized controlled trial comparing differential target multiplexed spinal cord stimulation and conventional spinal cord stimulation in subjects with chronic refractory axial low back pain not eligible for spine surgery. N Am Spine Soc J. 2024 Jul 17;19:100528.
  2. Fishman M, Cordner H, Justiz R, et al. Twelve-month results from multicenter, open-label, randomized controlled clinical trial comparing differential target multiplexed spinal cord stimulation and traditional spinal cord stimulation in subjects with chronic intractable back pain and leg pain. Pain Pract. 2021;21(8):912–923.
  3. Cedeno DL, Smith WJ, Kelley CA, Vallejo R. Spinal cord stimulation using differential target multiplexed programming modulates neural cell-specific transcriptomes in an animal model of neuropathic pain. Mol Pain. 2020;16:1744806920964360.
  4. Smith WJ, Cedeño DL, Thomas SM, Kelley CA, Vetri F, Vallejo R. Modulation of microglial activation states by spinal cord stimulation in an animal model of neuropathic pain: Comparing high rate, low rate, and differential target multiplexed programming. Mol Pain. 2021 Jan–Dec;17:1744806921999013.